THT 2023
THT 2023
  • About
    • About
    • Overview
    • CME
    • FAQ
    • Contact Us
    • Presenter Resources
  • Program
  • Attendance
  • Register

Overview

After a successful inaugural year of Technology and Heart Failure Therapeutics in 2022, CRF is proud to announce the second year of the conference, THT 2023. Building on the success of last year, and given the ever-growing prevalence of heart failure worldwide, we recognize a clear mandate for developing new monitoring strategies and treatment options to increase survival, decrease hospitalizations, and improve quality of life.

Covering a full range of updates on the current status of drug- and device-based treatments for heart failure across the spectrum of LV ejection fractions, THT 2023 is an immersive experience in the latest innovations that practitioners can put into practice for treating heart failure.

With unlimited opportunities for learning and global engagement, THT 2023 offers a future-oriented view of the pipeline for heart failure therapeutics, with a focus on in-development technologies (drugs, devices, monitoring strategies) that are currently in clinical trials — as well as an overview of the rapid advances in artificial intelligence and machine learning and how these technologies will transform the care of heart failure patients in the near future.

Learning Objectives

  • Obtain an up-to-date review of the current standards for the care of patients with heart failure across the spectrum of ejection fractions, etiologies and disease severities.
  • Understand the results of recently conducted studies of heart failure therapies (devices and drugs) that have not yet been incorporated into heart failure guidelines.
  • Understand the different types of monitoring and therapeutic devices that are currently under development for patients with acute and chronic heart failure and the status of ongoing clinical trials.
  • Understand how big data, artificial intelligence, machine learning and data-security matters are being incorporated into the management of heart failure patients.

A note about CME

Please note that CME credit is NOT available for online attendees. THT 2023 is CME-accredited only for participants who attend in person.

Who should attend THT 2023?

THT 2023 is designed for a multidisciplinary audience that includes anyone interested in heart failure management and a comprehensive overview of existing and investigational interventions. This includes:

  • Heart failure specialists (fellows, nurses, physicians, and research coordinators)
  • Cardiac imaging specialists
  • Cardiac and vascular surgeons
  • Clinical cardiologists
  • Fellows in interventional cardiovascular medicine and related fields
  • Industry professionals
  • Interventional cardiologists
  • Medical device experts
  • Nurse practitioners
  • Pharmaceutical executives
  • Pharmaceutical researchers
  • Physician assistants
  • Research scientists
CRF Logo

Sign Up for Our Newsletter

Get the latest news and information from CRF.

By submitting your email address, you agree to CRF's Privacy Policy & Terms and Conditions.

1700 Broadway, 9th Floor
New York, NY 10019
646.434.4500
[email protected]

© 2022, Cardiovascular Research Foundation. All rights reserved.

Privacy Policy
Terms and Conditions of Use

This website uses cookies to ensure you get the best experience on our website. Read More